CClinicalTrials.gg
CompletedNCT05443399Updated Aug 19, 2026Results posted

What Makes a Cup, a Cup? Generalizing Novel Words

An interventional study of Modality - 3D-2D and Modality - 2D-3D in Healthy, sponsored by Oklahoma State University. Completed at 1 site in United States. Open to participants aged 17 Months to 30 Months, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-08-19.

Sponsored by Oklahoma State University · Not applicable, Interventional, and Basic science

Phase
Not applicable
Study type
Interventional
Enrollment
212
Allocation
Randomized
Ages
17 Months to 30 Months
Sex
All
01

Study summary

The goal of this work is to address increasing concerns about young children's digital media exposure and language outcomes by testing how the times course of word learning unfolds in digital environments and the cascading impact of digital media on vocabulary outcomes. The findings will have important implications for understanding when and where optimal word learning from media can occur.

Read the detailed description

The goal of the current proposal is to identify how digital media alters the mechanisms of word learning and subsequently impacts the lexical foundation on which a child's vocabulary is built. Specifically, the proposal aims to identify the impact of digital media on 1) the processes underlying real-time word learning, and 2) the processes of language generalization and vocabulary growth. Specific Aim 1 will use a novel word learning task to test children's ability to map and retain new words within and between digital media (2D images on a tablet) and real world objects (3D objects). Specific Aim 2 will probe children's novel label generalization abilities within and between 2D and 3D modalities using a novel noun generalization task. Further, individual differences in a child's prior technology experience will be measured and used to predict overall vocabulary as well as performance within and between each task. This Clinical Trial record focuses on Specific Aim 2.

02

Conditions studied

  • Healthy
03

Who can participate

Ages eligible
17 Months to 30 Months
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • between 18-30 months old

Exclusion criteria

Exclusion Criteria:

  • diagnosed developmental delay or disorder
  • exposure to more than 25% of another language
04

Study design

Phase
Not applicable
Primary purpose
Basic science
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
212 participants (actual)

Study arms

  • No intervention
    3D-3D

    All items presented in 3D form.

  • Experimental
    3D-2D

    Initial exposure to items in 3D, generalization in 2D

    Behavioral: Modality - 3D-2D

  • Experimental
    2D-3D

    Initial exposure to items in 2D, generalization in 3D

    Behavioral: Modality - 2D-3D

  • Experimental
    2D-2D

    Initial exposure to items in 2D, generalization in 2D

    Behavioral: Modality - 2D-2D

Interventions

  • BehavioralModality - 3D-2D

    Modality in which items will be presented (via tablet/digital media or as real object). 3D items initially and generalization as 2D

    Also known as: digital media modality

  • BehavioralModality - 2D-3D

    Modality in which items will be presented (via tablet/digital media or as real object). 2D items initially and generalization as 3D

    Also known as: digital media modality

  • BehavioralModality - 2D-2D

    Modality in which items will be presented (via tablet/digital media or as real object). 2D items initially and generalization as 2D

    Also known as: digital media modality

05

What researchers measure

Primary outcomes

  1. Generalization Performance

    Accuracy on selecting the target item on novel noun generalization task, defined as percent of choices to the shape-matching item across all trials

    Time frame: 1 minute

06

Results

Posted Aug 19, 2026

Participant flow

Recruitment occurred in Stillwater, OK and Dallas, TX through known channels, snowball, and social media efforts

Participant flow — Overall Study
Milestone3D-3D3D-2D2D-3D2D-2D
Started55516046
Completed51475544
Not completed4452

Outcome measures

PrimaryGeneralization Performance

Accuracy on selecting the target item on novel noun generalization task, defined as percent of choices to the shape-matching item across all trials

Time frame:
1 minute
Reported as:
Mean · percent accuracy
Generalization Performance
percent accuracy3D-3D3D-2D2D-3D2D-2D
Generalization Performance44 ± 1751 ± 2445 ± 1755 ± 20

Adverse events

Collected over Adverse events were not collected. Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
3D-3D———
3D-2D———
2D-3D———
2D-2D———

Baseline characteristics

Age, Continuous
Age, Continuous(age in months)3D-3D3D-2D2D-3D2D-2DTotal
Mean24.24 ± 4.4823.94 ± 3.8524.06 ± 4.6524.00 ± 4.1324.06 ± 4.28
Sex: Female, Male
Sex: Female, Male(Participants)3D-3D3D-2D2D-3D2D-2DTotal
Female1718242584
Male34293119113
Race (NIH/OMB)
Race (NIH/OMB)(Participants)3D-3D3D-2D2D-3D2D-2DTotal
American Indian or Alaska Native00000
Asian20035
Native Hawaiian or Other Pacific Islander00000
Black or African American454013
White33374236148
More than one race1156325
Unknown or Not Reported10326
Ethnicity (NIH/OMB)
Ethnicity (NIH/OMB)(Participants)3D-3D3D-2D2D-3D2D-2DTotal
Hispanic or Latino10411631
Not Hispanic or Latino41434337164
Unknown or Not Reported00112
07

Study locations

1 site
  • Oklahoma State University
    Stillwater, Oklahoma 74078, United States
08

References and documents

Study documents

  • Protocol and statistical analysis plan · Jun 26, 2026

Documents are hosted by the registry — open the source record to download them.

Individual participant data

Plan to share: Yes — Studies proposed will be registered under the Open Science Framework (OSF) and resulting findings shared with the academic community through open science initiatives, including OSF and the sharing of videos (when permission is granted) on Databrary.

Supporting information: Study protocol, Sap, Analytic code

09

Registry details

Key details

Study ID
NCT05443399
Lead sponsor
Oklahoma State University
Collaborators
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Responsible party
Sarah Kucker (Assistant Professor, Southern Methodist University) — Principal investigator
First posted
Jul 5, 2022
Start date
Apr 7, 2022
Primary completion
Mar 29, 2025
Completion
Apr 30, 2025
Results posted
Aug 19, 2026
Last update
Aug 19, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jul 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion